fashion -WSS

fashion

author：explore 2025-09-30 01:02:57 - browse：4

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

focus

WSS

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Cancer, immunology, HIV research ensnared in fetal tissue politics

What Kate Middleton's cancer revelation might teach the world

STAT letters to the editor on burnt

FDA needs staff influx to meet gene therapy needs, Marks says

U.K. officials, researchers try to ease path for bespoke genetic treatments

focus

fashion

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Biotech investment managers search for lucrative opportunities

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Patients' immediate access to test results puts radiologists in a bind

Medical records are filled with copy

Asbestos ban is immediate, but health effects will linger for decades

Dobbs anniversary: the lost opportunity of abortion as health care

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

ChatGPT in medicine: STAT answers readers' burning questions

Pharma patents targeted by Biden in move to slash drug prices

knowledge

Diabetes management: Digital health tools fall short, study says

SCOTUS to consider access to abortion pill mifepristone

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

SCOTUS to consider access to abortion pill mifepristone

Asbestos ban is immediate, but health effects will linger for decades

Adam's Take: Intra

explore

focus

explore

entertainment